NCT03314207View on ClinicalTrials.gov

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
X-Linked Retinitis Pigmentosa
Trial Locations (3)

27710

Duke Eye Center, Duke University Medical Center, Durham

75231

Retina Foundation of the Southwest, Dallas

97239

Casey Eye Institute, Oregon Health and Sciences University, Portland

Sponsors
All Listed Sponsors
lead

Beacon Therapeutics

INDUSTRY

NCT03314207 - Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) | Biotech Hunter | Biotech Hunter